|
|
||||||||
From the Division of Neurology (Drs. Paty, Oger, Kastrukoff, Hashimoto, Hooge, A. A. Eisen, Purves, and Low, and Ms. Brandejs and K. A. Eisen), Department of Medicine, the Department of Diagnostic Radiology (Drs. Robertson and Li), and the Imaging Research Center, University of British Columbia, Vancouver, British Columbia, Canada.
We compared the diagnostic capabilities of MRI to CT, evoked potentials (EP), and CSF oligoclonal banding analysis in a prospective evaluation of 200 patients with suspected multiple sclerosis (MS). MRI was the best method for demonstrating dissemination in space. An abnormal appropriate EP in monosymptomatic disease was usually supported by MRI and CSF anaylsis as being predictive of MS as a clinical diagnosis. A normal appropriate EP study was not satisfactory because MRI and CSF analysis often did not support a diagnosis of non-MS. When there is agreement between three of these paraclinical studies, the diagnosis of MS is probably unequivocal. For use in research studies, laboratory-supported definite MS (LSDMS) could be diagnosed in 85 patients of the total 200 (42.5%), in 19/38 (50%) of optic neuritis (ON) patients, and in 24/52 (46%) of chronic progressive myelopathy (CPM) patients. MRI was 100% successful in identifying patients who qualified for LSDMS in the ON and CPM groups. In a short follow-up (less than 1 year), 19/200 (10%) went on to develop clinically definite MS (CDMS), and MRI predicted that diagnosis in 18/19 (95%). Only long-term follow-up will show how well these studies and the category of LSDMS predict the development of CDMS. The clinical diagnosis of MS (CDMS), even though only 95% accurate, must remain the gold standard.
Address correspondence and reprint requests to Dr. Paty, Division of Neurology, Vancouver General Hospital, 2222775 Heather Street, Vancouver, B. C., Canada V5Z 3J5.
Supported by grants from the Medical Research Council of Canada and the Jacob W. Cohen Fund for Research into Multiple Sclerosis.
Presented in part at the thirty-eighth annual meeting of the American Academy of Neurology, New Orleans, LA, April 1986; and the annual meetings of the American Association of Electromyography and Electrodiagnosis, Boston, MA, September 1986; the American EEG Society, Seattle, WA, November 1986; the Society for Magnetic Resonance, Montreal, Canada, 1986; and the NATO MS Workshop, Brussels, Belgium, 1986.
Received March 16, 1987. Accepted for publication in final form May 11, 1987.
This article has been cited by other articles:
![]() |
T Matsushita, N Isobe, T Matsuoka, N Shi, Y Kawano, X. Wu, T Yoshiura, Y Nakao, T Ishizu, and J. Kira Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese Multiple Sclerosis, July 1, 2009; 15(7): 834 - 847. [Abstract] [PDF] |
||||
![]() |
A. Rovira, J. Swanton, M. Tintore, E. Huerga, F. Barkhof, M. Filippi, J. L. Frederiksen, A. Langkilde, K. Miszkiel, C. Polman, et al. A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis Arch Neurol, May 1, 2009; 66(5): 587 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seewann, H. Vrenken, P. van der Valk, E. L. A. Blezer, D. L. Knol, J. A. Castelijns, C. H. Polman, P. J. W. Pouwels, F. Barkhof, and J. J. G. Geurts Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis Arch Neurol, May 1, 2009; 66(5): 601 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dickinson, D. Perera, A. van der Mei, A-L Ponsonby, A. Polanowski, R. Thomson, B. Taylor, J. McKay, J Stankovich, and T Dwyer Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction Multiple Sclerosis, May 1, 2009; 15(5): 563 - 570. [Abstract] [PDF] |
||||
![]() |
D.J.A. Callen, M. M. Shroff, H. M. Branson, T. Lotze, D. K. Li, D. Stephens, and B. L. Banwell MRI in the diagnosis of pediatric multiple sclerosis Neurology, March 17, 2009; 72(11): 961 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
F G Joseph, C L Hirst, T P Pickersgill, Y Ben-Shlomo, N P Robertson, and N J Scolding CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 292 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Broadley, D Vanags, B Williams, B Johnson, D Feeney, L Griffiths, S Shakib, G Brown, A Coulthard, P Mullins, et al. Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis Multiple Sclerosis, March 1, 2009; 15(3): 329 - 336. [Abstract] [PDF] |
||||
![]() |
H. Merle, S. Olindo, A. Donnio, R. Richer, D. Smadja, and P. Cabre Retinal Peripapillary Nerve Fiber Layer Thickness in Neuromyelitis Optica Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4412 - 4417. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dwyer, I. van der Mei, A-L Ponsonby, B. V. Taylor, J. Stankovich, J. D. McKay, R. J. Thomson, A. M. Polanowski, and J. L. Dickinson Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis Neurology, August 19, 2008; 71(8): 583 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis Brain, July 1, 2008; 131(7): 1759 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsushita, T. Matsuoka, T. Ishizu, H. Kikuchi, M. Osoegawa, Y. Kawano, F. Mihara, Y. Ohyagi, and J.-i. Kira Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study Multiple Sclerosis, April 1, 2008; 14(3): 343 - 353. [Abstract] [PDF] |
||||
![]() |
M. J. Dinkin, D. M. Cestari, M. C. Stein, S. D. Brass, and S. Lessell NMO Antibody-Positive Recurrent Optic Neuritis Without Clear Evidence of Transverse Myelitis Arch Ophthalmol, April 1, 2008; 126(4): 566 - 570. [Full Text] [PDF] |
||||
![]() |
R. Eichel, Z. Meiner, O. Abramsky, and M. Gotkine Acute Disseminating Encephalomyelitis in Neuromyelitis Optica: Closing the Floodgates Arch Neurol, February 1, 2008; 65(2): 267 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuoka, T. Matsushita, Y. Kawano, M. Osoegawa, H. Ochi, T. Ishizu, M. Minohara, H. Kikuchi, F. Mihara, Y. Ohyagi, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese Brain, May 1, 2007; 130(5): 1206 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Banwell The long (-itudinally extensive) and the short of it: Transverse myelitis in children Neurology, May 1, 2007; 68(18): 1447 - 1449. [Full Text] [PDF] |
||||
![]() |
B. Banwell, M. Shroff, J. M. Ness, D. Jeffery, S. Schwid, B. Weinstock-Guttman, and for the International Pediatric MS Study Group MRI features of pediatric multiple sclerosis Neurology, April 17, 2007; 68(16_suppl_2): S46 - S53. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.A.F. van der Mei, L. Blizzard, A-L. Ponsonby, and T. Dwyer Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1538 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Wingerchuk, V. A. Lennon, S. J. Pittock, C. F. Lucchinetti, and B. G. Weinshenker Revised diagnostic criteria for neuromyelitis optica Neurology, May 23, 2006; 66(10): 1485 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.S. Yu, F.C. Lin, K.C. Li, T.Z. Jiang, C.Z. Zhu, W. Qin, H. Sun, and P. Chan Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1009 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. O'Connor, D. Li, M. S. Freedman, A. Bar-Or, G.P.A. Rice, C. Confavreux, D. W. Paty, J. A. Stewart, R. Scheyer, and on behalf of the Teriflunomide Multiple Sclerosis A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses Neurology, March 28, 2006; 66(6): 894 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
E T Lim, F Sellebjerg, C V Jensen, D R Altmann, D Grant, G Keir, E J Thompson, and G Giovannoni Acute axonal damage predicts clinical outcome in patients with multiple sclerosis Multiple Sclerosis, October 1, 2005; 11(5): 532 - 536. [Abstract] [PDF] |
||||
![]() |
W. Staffen, H. Zauner, A. Mair, A. Kutzelnigg, P. Kapeller, H. Stangl, E. Raffer, H. Niederhofer, and G. Ladurner Magnetic Resonance Spectroscopy of Memory and Frontal Brain Region in Early Multiple Sclerosis J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 357 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
R C Dale and J A Branson Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch. Dis. Child., June 1, 2005; 90(6): 636 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Roed, A. Langkilde, F. Sellebjerg, M. Lauritzen, P. Bang, A. Morup, and J. L. Frederiksen A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis Neurology, March 8, 2005; 64(5): 804 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laura, W. Leong, N. M.F. Murray, G. Ingle, K. A. Miszkiel, D. R. Altmann, D. H. Miller, and M. M. Reilly Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord Neurology, March 8, 2005; 64(5): 914 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H Polman, J. S Wolinsky, and S. C Reingold Multiple sclerosis diagnostic criteria: three years later Multiple Sclerosis, February 1, 2005; 11(1): 5 - 12. [Abstract] [PDF] |
||||
![]() |
A.-L. Ponsonby, I. van der Mei, T. Dwyer, L. Blizzard, B. Taylor, A. Kemp, R. Simmons, and T. Kilpatrick Exposure to Infant Siblings During Early Life and Risk of Multiple Sclerosis JAMA, January 26, 2005; 293(4): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bakshi, G. J. Hutton, J. R. Miller, and E.-W. Radue The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis Neurology, December 14, 2004; 63(11_suppl_5): S3 - S11. [Abstract] [Full Text] |
||||
![]() |
A. Kheradvar, A. R. Tabassi, B. Nikbin, F. Khosravi, M. Naroueynejad, B. Moradi, and A. A. Amirzargar Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study Multiple Sclerosis, October 1, 2004; 10(5): 526 - 531. [Abstract] [PDF] |
||||
![]() |
E T Lim, D Grant, M Pashenkov, G Keir, E J Thompson, M Soderstrom, and G Giovannoni Cerebrospinal fluid levels of brain specific proteins in optic neuritis Multiple Sclerosis, June 1, 2004; 10(3): 261 - 265. [Abstract] [PDF] |
||||
![]() |
C. D. Hahn, M. M. Shroff, S. I. Blaser, and B. L. Banwell MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort Neurology, March 9, 2004; 62(5): 806 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Asghar-Ali, K. H. Taber, R. A. Hurley, and L. A. Hayman Pure Neuropsychiatric Presentation of Multiple Sclerosis Am J Psychiatry, February 1, 2004; 161(2): 226 - 231. [Full Text] [PDF] |
||||
![]() |
J. Sastre-Garriga, M. Tintore, A. Rovira, C. Nos, J. Rio, A. J. Thompson, and X. Montalban Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes Arch Neurol, February 1, 2004; 61(2): 222 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C.J. Bot, F. Barkhof, C. H. Polman, G.J. L. a Nijeholt, V. de Groot, E. Bergers, H. J. Ader, and J. A. Castelijns Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination Neurology, January 27, 2004; 62(2): 226 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Zipoli, E Portaccio, G Siracusa, G Pracucci, S Sorbi, and M P Amato Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis Multiple Sclerosis, October 1, 2003; 9(5): 481 - 485. [Abstract] [PDF] |
||||
![]() |
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, et al. The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, September 9, 2003; 61(5): 602 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
I A F van der Mei, A-L Ponsonby, T Dwyer, L Blizzard, R Simmons, B V Taylor, H Butzkueven, and T Kilpatrick Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study BMJ, August 9, 2003; 327(7410): 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y P Jin, J de Pedro-Cuesta, Y H Huang, and M Soderstrom Predicting multiple sclerosis at optic neuritis onset Multiple Sclerosis, April 1, 2003; 9(2): 135 - 141. [Abstract] [PDF] |
||||
![]() |
G V McDonnell, J Cabrera-Gomez, D B Calne, D K. Li, and J Oger Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: The subclinical stage of primary progressive multiple sclerosis may last 10 years Multiple Sclerosis, April 1, 2003; 9(2): 204 - 209. [Abstract] [PDF] |
||||
![]() |
J Sastre-Garriga, M Tintore, A Rovira, E Grive, I Pericot, M Comabella, A J Thompson, and X Montalban C onversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fl uid and neurophysiological findings Multiple Sclerosis, February 1, 2003; 9(1): 39 - 43. [Abstract] [PDF] |
||||
![]() |
F Sellebjerg, C V Jensen, H B. Larsson, and J L Frederiksen Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis Multiple Sclerosis, February 1, 2003; 9(1): 102 - 107. [Abstract] [PDF] |
||||
![]() |
CHAMPS Study Group MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group Neurology, October 8, 2002; 59(7): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
R M Papais-Alvarenga, C M Miranda-Santos, M Puccioni-Sohler, A M V de Almeida, S Oliveira, C A B. De Oliveira, H Alvarenga, and C M Poser Optic neuromyelitis syndrome in Brazilian patients J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 429 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O'Connor Key issues in the diagnosis and treatment of multiple sclerosis: An overview Neurology, September 24, 2002; 59(90063): S1 - 33. [Full Text] |
||||
![]() |
M. Rovaris, M. Holtmannspotter, M. Rocca, G. Iannucci, M. Codella, B. Viti, A. Campi, G. Comi, T. Yousry, and M. Filippi Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study Multiple Sclerosis, September 1, 2002; 8(1_suppl): 52 - 58. [Abstract] [PDF] |
||||
![]() |
A. van der Meijs, I. Tan, and F. Barkhof Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis Multiple Sclerosis, September 1, 2002; 8(1_suppl): 64 - 67. [Abstract] [PDF] |
||||
![]() |
H. McFarland The emerging role of MRI in multiple sclerosis and the new diagnostic criteria Multiple Sclerosis, September 1, 2002; 8(1_suppl): 71 - 72. [PDF] |
||||
![]() |
CHAMPS Study Group Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial Multiple Sclerosis, August 1, 2002; 8(4): 330 - 338. [Abstract] [PDF] |
||||
![]() |
W. Staffen, A. Mair, H. Zauner, J. Unterrainer, H. Niederhofer, A. Kutzelnigg, S. Ritter, S. Golaszewski, B. Iglseder, and G. Ladurner Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task Brain, June 1, 2002; 125(6): 1275 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Arnold and P.M. Matthews MRI in the diagnosis and management of multiple sclerosis Neurology, April 23, 2002; 58(90084): S23 - 31. [Abstract] [Full Text] |
||||
![]() |
A Ghezzi, C Pozzilli, M Liguori, M G Marrosu, N Milani, C Milanese, I Simone, and M Zaffaroni Prospective study of multiple sclerosis with early onset Multiple Sclerosis, April 1, 2002; 8(2): 115 - 118. [Abstract] [PDF] |
||||
![]() |
M Rovaris, M Holtmannspotter, M A Rocca, G Iannucci, M Codella, B Viti, A Campi, G Comi, T A Yousry, and M Filippi Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study Multiple Sclerosis, February 1, 2002; 8(1): 52 - 58. [Abstract] [PDF] |
||||
![]() |
A H. van der Meijs, I L Tan, and F Barkhof Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis Multiple Sclerosis, February 1, 2002; 8(1): 64 - 67. [Abstract] [PDF] |
||||
![]() |
H F McFarland The emerging role of MRI in multiple sclerosis and the new diagnostic criteria Multiple Sclerosis, February 1, 2002; 8(1): 71 - 72. [PDF] |
||||
![]() |
M Tintore, A Rovira, L Brieva, E Grive, R Jardi, C Borras, and X Montalban Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS Multiple Sclerosis, December 1, 2001; 7(6): 359 - 363. [Abstract] [PDF] |
||||
![]() |
E. M. Frohman, H. Zhang, P. D. Kramer, J. Fleckenstein, K. Hawker, M. K. Racke, and T. C. Frohman MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis Neurology, September 11, 2001; 57(5): 762 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. de Seze, T. Stojkovic, G. Breteau, C. Lucas, U. Michon-Pasturel, J.-Y. Gauvrit, E. Hachulla, F. Mounier-Vehier, J.-P. Pruvo, D. Leys, et al. Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases Brain, August 1, 2001; 124(8): 1509 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schwarz, A. Mohr, M. Knauth, B. Wildemann, and B. Storch-Hagenlocher Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients Neurology, May 22, 2001; 56(10): 1313 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Belopitova, V. Guergueltcheva, and V. Bojinova Definite and Suspected Multiple Sclerosis in Children: Long-Term Follow-up and Magnetic Resonance Imaging Findings J Child Neurol, May 1, 2001; 16(5): 317 - 324. [Abstract] [PDF] |
||||
![]() |
J. Pelletier, L. Suchet, T. Witjas, M. Habib, C. R. G. Guttmann, G. Salamon, O. Lyon-Caen, and A. A. Cherif A Longitudinal Study of Callosal Atrophy and Interhemispheric Dysfunction in Relapsing-Remitting Multiple Sclerosis Arch Neurol, January 1, 2001; 58(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. W. Moore, E. Leung, A. L. MacKay, I. M. Vavasour, K. P. Whittall, K. S. Cover, D. K. B. Li, S. A. Hashimoto, J. Oger, T. J. Sprinkle, et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain Neurology, November 28, 2000; 55(10): 1506 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Filippi Enhanced magnetic resonance imaging in multiple sclerosis Multiple Sclerosis, October 1, 2000; 6(5): 320 - 326. [Abstract] [PDF] |
||||
![]() |
D. W. Paty Ultrasound Measurement of Brain Atrophy in Multiple Sclerosis Arch Neurol, September 1, 2000; 57(9): 1264 - 1264. [Full Text] [PDF] |
||||
![]() |
G. Iannucci, C. Tortorella, M. Rovaris, M. P. Sormani, G. Comi, and M. Filippi Prognostic Value of MR and Magnetization Transfer Imaging Findings in Patients withClinically Isolated Syndromes Suggestive ofMultiple Sclerosis at Presentation AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1034 - 1038. [Abstract] [Full Text] |
||||
![]() |
J. S. Kaiser, R. I. Grossman, M. Polansky, J. K. Udupa, Y. Miki, and S. L. Galetta Magnetization Transfer Histogram Analysis of Monosymptomatic Episodes of Neurologic Dysfunction: Preliminary Findings AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1043 - 1047. [Abstract] [Full Text] |
||||
![]() |
G. S. Gronseth and E. J. Ashman Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, May 9, 2000; 54(9): 1720 - 1725. [Full Text] [PDF] |
||||
![]() |
M Kremenchutzky, D Lee, G P A Rice, and G C Ebers Diagnostic brain MRI findings in primary progressive multiple sclerosis Multiple Sclerosis, April 1, 2000; 6(2): 81 - 85. [Abstract] [PDF] |
||||
![]() |
I L Tan, G J L. Nijeholt, C H Polman, H J Ader, F Barkhof, and the 95 Line 146/147 Study Group Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials Multiple Sclerosis, April 1, 2000; 6(2): 99 - 104. [Abstract] [PDF] |
||||
![]() |
M. Tintoré, A. Rovira, M. J. Martínez, J. Rio, P. Díaz-Villoslada, L. Brieva, C. Borrás, E. Grivé, J. Capellades, and X. Montalban Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 702 - 706. [Abstract] [Full Text] |
||||
![]() |
S. Mata, F. Lolli, M. Soderstrom, F. Pinto, and H. Link Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD I a Multiple Sclerosis, December 1, 1999; 5(6): 379 - 388. [Abstract] [PDF] |
||||
![]() |
M. Filippi, M. A. Rocca, M. Wiessmann, S. Mennea, M. Cercignani, T. A. Yousry, M. P. Sormani, and G. Comi A Comparison of MR Imaging with Fast-FLAIR, HASTE-FLAIR, and EPI-FLAIR Sequences in the Assessment of Patients with Multiple Sclerosis AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1931 - 1938. [Abstract] [Full Text] |
||||
![]() |
M. A. Hernan, M. J. Olek, and A. Ascherio Geographic variation of MS incidence in two prospective studies of US women Neurology, November 1, 1999; 53(8): 1711 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Wingerchuk, W. F. Hogancamp, P. C. O'Brien, and B. G. Weinshenker The clinical course of neuromyelitis optica (Devic's syndrome) Neurology, September 1, 1999; 53(5): 1107 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mastronardo, M. A. Rocca, G. Iannucci, C. Pereira, and M. Filippi A Longitudinal MR Study of the Presymptomatic Phase in a Patient with Clinically Definite Multiple Sclerosis AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1268 - 1272. [Abstract] [Full Text] |
||||
![]() |
F. Fazekas, F. Barkhof, M. Filippi, R. I. Grossman, D. K. B. Li, W. I. McDonald, H. F. McFarland, D. W. Paty, J. H. Simon, J. S. Wolinsky, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis Neurology, August 1, 1999; 53(3): 448 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filippi, M. A. Rocca, L. Minicucci, V. Martinelli, A. Ghezzi, R. Bergamaschi, and G. Comi Magnetization transfer imaging of patients with definite MS and negative conventional MRI Neurology, March 1, 1999; 52(4): 845 - 845. [Abstract] [Full Text] |
||||
![]() |
M. Sailer, J. I. O'Riordan, A. J. Thompson, D. P. Kingsley, D. G. MacManus, W. I. McDonald, and D. H. Miller Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination Neurology, February 1, 1999; 52(3): 599 - 599. [Abstract] [Full Text] |
||||
![]() |
J L Frederiksen Can CSF predict the course of optic neuritis? Multiple Sclerosis, June 1, 1998; 4(3): 132 - 135. [Abstract] [PDF] |
||||
![]() |
A. Tourbah, A. Clapin, O. Gout, B. Fontaine, R. Liblau, F. Batteux, J.-L. Stievenart, B. Weill, C. Lubetzki, and O. Lyon-Caen Systemic Autoimmune Features and Multiple Sclerosis: A 5-Year Follow-up Study Arch Neurol, April 1, 1998; 55(4): 517 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Khoury and H. L. Weiner Multiple Sclerosis: What Have We Learned From Magnetic Resonance Imaging Studies? Arch Intern Med, March 23, 1998; 158(6): 565 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
J I O'Riordan, N A Losseff, C Phatouros, A J Thompson, I F Moseley, D G MacManus, W I McDonald, and D H Miller Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 353 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Frederiksen and C. J. Sindic Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI Multiple Sclerosis, February 1, 1998; 4(1): 22 - 26. [Abstract] [PDF] |
||||
![]() |
C A Davie, G J Barker, A J Thompson, P S Tofts, W I McDonald, and D H Miller 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, December 1, 1997; 63(6): 736 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Thomke, E. Lensch, K. Ringel, and H. C. Hopf Isolated cranial nerve palsies in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 682 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barkhof Imaging of remyelination Multiple Sclerosis, April 1, 1997; 3(2): 129 - 132. [Abstract] [PDF] |
||||
![]() |
{blacktriangledown}Interferon beta-1b - hope or hype? DTB, February 1, 1996; 34(2): 9 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Soderstrom, J Hillert, J Link, V Navikas, S Fredrikson, and H Link Expression of IFN-{gamma}, IL-4, and TGF-{beta} in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease Multiple Sclerosis, November 1, 1995; 1(3): 173 - 180. [Abstract] [PDF] |
||||
![]() |
M. P. Amato, G. Ponziani, G. Pracucci, L. Bracco, G. Siracusa, and L. Amaducci Cognitive Impairment in Early-Onset Multiple Sclerosis: Pattern, Predictors, and Impact on Everyday Life in a 4-Year Follow-up Arch Neurol, February 1, 1995; 52(2): 168 - 172. [Abstract] [PDF] |
||||
![]() |
D. E. Goodkin, R. A. Rudick, and J. S. Ross The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis Arch Neurol, May 1, 1994; 51(5): 505 - 516. [Abstract] [PDF] |
||||
![]() |
P. O'Connor, C. Tansey, W. Kucharczyk, A. S. Detsky, and Rochester-Toronto MRI Study Group A Randomized Trial of Test Result Sequencing in Patients With Suspected Multiple Sclerosis Arch Neurol, January 1, 1994; 51(1): 53 - 59. [Abstract] [PDF] |
||||
![]() |
D. W. Giang, V. M. Grow, C. Mooney, A. I. Mushlin, A. D. Goodman, D. H. Mattson, R. B. Schiffer, and Rochester-Toronto Magnetic Resonance Study Group Clinical Diagnosis of Multiple Sclerosis: The Impact of Magnetic Resonance Imaging and Ancillary Testing Arch Neurol, January 1, 1994; 51(1): 61 - 66. [Abstract] [PDF] |
||||
![]() |
R. W. Beck, J. Arrington, F. R. Murtagh, P. A. Cleary, D. I. Kaufman, and Optic Neuritis Study Group Brain Magnetic Resonance Imaging in Acute Optic Neuritis: Experience of the Optic Neuritis Study Group Arch Neurol, August 1, 1993; 50(8): 841 - 846. [Abstract] [PDF] |
||||
![]() |
A. I. Mushlin, A. S. Detsky, C. E. Phelps, P. W. O'Connor, D. K. Kido, W. Kucharczyk, D. W. Giang, C. Mooney, C. M. Tansey, W. J. Hall, et al. The Accuracy of Magnetic Resonance Imaging in Patients With Suspected Multiple Sclerosis JAMA, June 23, 1993; 269(24): 3146 - 3151. [Abstract] [PDF] |
||||
![]() |
K. Syndulko, W. W. Tourtellotte, R. W. Baumhefner, G. W. Ellison, L. W. Myers, G. Belendiuk, and G. V. Kondraske Neuroperformance Evaluation of Multiple Sclerosis Disease Progression in a Clinical Trial: Implications for Neurological Outcomes Neurorehabil Neural Repair, January 1, 1993; 7(3-4): 153 - 176. [PDF] |
||||
![]() |
A. Gessain and O. Gout Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I) Ann Intern Med, December 1, 1992; 117(11): 933 - 946. [Abstract] [PDF] |
||||
![]() |
R. A. Rudick The Value of Brain Magnetic Resonance Imaging in Multiple Sclerosis Arch Neurol, July 1, 1992; 49(7): 685 - 686. [Abstract] [PDF] |
||||
![]() |
M. Ramirez-Lassepas, J. W. Tulloch, M. R. Quinones, and B. D. Snyder Acute Radicular Pain as a Presenting Symptom in Multiple Sclerosis Arch Neurol, March 1, 1992; 49(3): 255 - 258. [Abstract] [PDF] |
||||
![]() |
D. E. Goodkin, T. H. Doolittle, S. S. Hauser, R. M. Ransohoff, A. D. Roses, and R. A. Rudick Diagnostic Criteria for Multiple Sclerosis Research Involving Multiply Affected Families Arch Neurol, August 1, 1991; 48(8): 805 - 807. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |